搜尋
BCPE Perseus Investor Ord Shs (Proposed)
KLRA添加自選
23.170USD
+0.230+1.00%
收盤 06/01, 16:00（美東）報價延遲15分鐘
2.97B總市值
--本益比TTM
關於 BCPE Perseus Investor Ord Shs (Proposed) 公司
Kailera Therapeutics Inc is a United States-based company. The Company is a clinical-stage biopharmaceutical company developing a broad and advanced therapeutic pipeline that is poised to deliver differentiated treatment options for obesity and related conditions. Its pipeline consists of clinical- and preclinical-stage programs with injectable peptides, oral peptides, and an oral small molecule.
BCPE Perseus Investor Ord Shs (Proposed)簡介
公司代碼KLRA
公司名稱Kailera Therapeutics Inc
上市日期Apr 17, 2026
CEORenaud (Ron)
員工數量- -
證券類型Ordinary Share
年結日- -
公司地址180 Third Ave
城市WALTHAM
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編02451
電話15084409475
網址https://www.kailera.com
公司代碼KLRA
上市日期Apr 17, 2026
CEORenaud (Ron)
BCPE Perseus Investor Ord Shs (Proposed)公司高管
名稱
名稱/職務
職務
持股
持股變動
,
,
--
--
Mr. Ron Renaud
Mr. Ron Renaud
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Paul Burgess
Mr. Paul Burgess
Chief Operating Officer, Chief Business Officer
Chief Operating Officer, Chief Business Officer
--
--
Ms. Paula Cloghessy
Ms. Paula Cloghessy
Chief People Officer
Chief People Officer
--
--
Mr. Scott M. Akamine, J.D.
Mr. Scott M. Akamine, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
--
--
Ms. Jamie Coleman
Ms. Jamie Coleman
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Douglas W. Pagan
Mr. Douglas W. Pagan
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Scott Wasserman, M.D.
Dr. Scott Wasserman, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Franklin K. (Frank) Clyburn, Jr.
Mr. Franklin K. (Frank) Clyburn, Jr.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
,
,
--
--
Mr. Ron Renaud
Mr. Ron Renaud
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Paul Burgess
Mr. Paul Burgess
Chief Operating Officer, Chief Business Officer
Chief Operating Officer, Chief Business Officer
--
--
Ms. Paula Cloghessy
Ms. Paula Cloghessy
Chief People Officer
Chief People Officer
--
--
Mr. Scott M. Akamine, J.D.
Mr. Scott M. Akamine, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
--
--
Ms. Jamie Coleman
Ms. Jamie Coleman
Chief Commercial Officer
Chief Commercial Officer
--
--
收入明細
由於公司未披露，未能獲取相關數據
由於公司未披露，未能獲取相關數據
業務
地區
由於公司未披露，未能獲取相關數據
股東統計
更新時間: 4月29日 週三
更新時間: 4月29日 週三
持股股東
股東類型
持股股東
持股股東
佔比
Bain Capital Private Equity, LP
20.27%
Bain Capital Life Sciences Investors, LLC
17.43%
其他
62.30%
持股股東
持股股東
佔比
Bain Capital Private Equity, LP
20.27%
Bain Capital Life Sciences Investors, LLC
17.43%
其他
62.30%
股東類型
持股股東
佔比
Private Equity
20.27%
Investment Advisor
17.43%
其他
62.30%
機構持股
由於公司未披露，未能獲取相關數據
報告期間
機構數
持股數
持股佔比
持股變動
暫無數據
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
暫無數據
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
